1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Sanara MedTech Inc.

Sanara MedTech Inc.

SMTI
Sanara MedTech Inc.US flagNASDAQ Capital Market
25.00
USD
- -
- -
229.10MMarket Cap
Sanara MedTech Inc.
SMTI
(NASDAQ Capital Market)

Recent

price

25.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2.54
3.76
1.71
2.02
2.5
3.14
5.02
5.66
2.69
3.3
2.72
3.29
5.8
7.85
10.22
11.96
12.49
Revenue per Share
-18.54
-21.69
-2.68
-4.85
-2.38
-1.5
-0.62
0.17
-0.34
-0.79
-0.76
-1.08
-1
-0.52
-1.14
-4.36
-3.9
Basic EPS, GAAP
-4.17
-0.58
-1.78
-2.16
-1.61
-1.13
0.37
-0.2
0.12
-1.08
-0.99
-0.76
-0.8
-0.42
-0.03
0.25
0.39
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-68.08
-63.17
-56.63
-50.29
-43
-43.51
-42.93
-41.98
0.06
-0.75
-1.23
-2.07
-2.96
-3.39
-4.45
-8.73
-8.65
Book Value per Share
-9.92
-7.31
-6.03
-3.85
-1.68
-2.11
-1.29
-0.78
-4.96
-1.81
0.48
3.46
0.84
-0.48
1.39
-1.89
-1.68
Tangible Book Value per Share
- -
1
1
1
1
1
1
1
2
4
6
7
8
8
8
9
9
Basic Weighted Avg Shares
1
2
1
2
3
3
6
6
6
12
16
24
46
65
87
103
108
Sales/Revenue/Turnover
-271.94
-58.52
-459.42
-169.63
-78.34
-28.42
-4.75
2.26
-8.38
-22.35
-32.3
-30.55
-26.68
-11.79
1.44
8.87
7.86
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
2
4
5
4
3
Depreciation Expense
-7
-13
-2
-4
-2
-1
- -
- -
-1
-3
-4
-8
-8
-4
-10
-38
-34
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-729.53
-576.59
-157.24
-240.27
-86.54
-39.75
-7.55
5.25
-10.29
-23.92
-27.95
-32.81
-17.31
-6.62
-11.15
-36.43
-31.23
Profit Margin (%)
-5
-5
-4
-3
-1
- -
1
- -
1
6
1
19
8
5
18
15
17
Working Capital
- -
1
- -
- -
- -
1
1
- -
- -
2
- -
- -
1
11
32
48
48
LT Debt
1
-4
-4
-2
-1
-1
- -
- -
1
6
6
30
42
45
39
6
7
Total Equity
- -
- -
- -
- -
- -
- -
- -
11.66
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
-1.03
- -
- -
- -
- -
- -
- -
- -
- -
288.75
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
45
46
46
LT Finance Leases
2
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
273
200
148

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
31
34
31
Cash, Cash Equivalents & STI
15
17
14
Accounts Receivable, Net
12
12
14
Inventories
3
4
3
Total Current Liabilities
17
19
14
Payables & Accruals
4
5
4
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
162.61%
72.81%
-84.76%
Free Cash Flow
-307.35%
-214.09%
-944.59%
Net Income, GAAP
34.29%
89.9%
288.66%
Sales/Revenue/Turnover
44.33%
47.77%
18.97%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
19
20
22
26
87
2025
23
26
26
28
103
2026
28
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.21
-0.41
-0.34
-0.18
-1.14
2025
-0.41
-0.23
-3.52
-0.19
-4.36
2026
0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Tarsons Products Limited (TARSONS.BO)
Fielmann AG (FLMNF)
Kestra Medical Technologies, Ltd. (KMTS)
Medivolve Inc (MEDVD)
Maxigen Biotech Inc. (1783.TW)
Asahi Intecc Co., Ltd. (AHICF)
Business
Sanara MedTech Inc. (NASDAQ: SMTI), a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings primarily in the United States. Founded in 2001 and headquartered in Fort Worth, Texas, the company offers CellerateRX Surgical Activated Collagen Powder, a hydrolyzed Type I bovine collagen for surgical, traumatic, and burn wounds; BIASURGE Advanced Surgical Solution, a no-rinse antimicrobial irrigation solution; FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix, both porcine small intestinal submucosa-based products for soft tissue reinforcement; TEXAGEN Amniotic Membrane Allograft, a multilayer barrier for wounds; ALLOCYTE Plus Advanced Viable Bone Matrix, a cellular bone allograft; BiFORM Bioactive Moldable Matrix, an osteoconductive bone graft; ACTIGEN Verified Inductive Bone Matrix, a differentiated allograft; BIAKŌS Antimicrobial Skin and Wound Cleanser, Gel, and Irrigation Solution; and HYCOL Hydrolyzed Collagen for chronic wound care. Sanara MedTech recently secures a $55 million non-dilutive debt facility from CRG Servicing LLC in April 2024 to fund growth initiatives, permitted acquisitions, and working capital, with $15 million drawn initially and up to $40 million more available through June 2025; enters an exclusive U.S. distribution agreement with InfuSystem Holdings Inc. for ChemoMouthpiece oral cryotherapy device in September 2024, accompanied by a $5 million investment for 6.6% ownership to expand skincare offerings for oncology patients; and reports third-quarter 2025 net revenue of $26.3 million, up 22% from the prior year, alongside expansions into virtual wound and skin care telemedicine services.

Company News

APIChatGPT

  • gurufocus.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

  • seekingalpha.com

    Sanara MedTech: From Cash Burner To Profitable Growth

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

  • seekingalpha.com

    Sanara MedTech Inc. (SMTI) Q1 2026 Earnings Call Transcript

  • globenewswire.com

    Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)

  • globenewswire.com

    Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)

  • globenewswire.com

    SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm

  • globenewswire.com

    SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

  • seekingalpha.com

    White Brook Capital Partners: Stocks We Believe Will Be Meaningful Contributors

  • globenewswire.com

    Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026

  • globenewswire.com

    Sanara MedTech, Inc. Investigated by the Portnoy Law Firm

  • defenseworld.net

    Reviewing Sanara MedTech (NASDAQ:SMTI) & ICU Medical (NASDAQ:ICUI)

  • seekingalpha.com

    Sanara MedTech Inc. (SMTI) Q4 2025 Earnings Call Transcript